The Biden administration temporarily lifted restrictions on abortion by drugs requiring direct dispensing of abortion drugs, overturned Trump era policy, and handed the abortion group one of the first major victories of the new administration. I will.
In a two-page letter to a specialized medical institution, the American College of Obstetrics and Gynecologists, FDA Commissioner Janet Woodcock said on Monday night that an abortion patient had an abortion using mifepristone from a healthcare provider. Get the pill directly. This decision allows healthcare providers in some states to prescribe and mail tablets via telemedicine.
Woodcock quoted four medical publications: “These studies raise serious safety concerns about medical abortion as a result of changing face-to-face dispensing requirements during the COVID-19 pandemic. It doesn’t seem to show it. “
Monday night’s decision overturns the Trump administration’s policy upheld by the Supreme Court earlier this year. Last year, ACOG, which accounted for about 90% of obstetricians and gynecologists in the field, had two first pills used to induce abortion, mifepristone (also sold as mifepristone). The doctor will dispense directly. The medical group argued that not only were face-to-face requirements medically unnecessary, but in the COVID-19 pandemic situation, patients and medical staff were at risk of being exposed to the virus.
When the FDA denied the request, the ACOG-Medical Association filed a proceeding, and in July a federal court agreed to temporarily suspend the FDA’s face-to-face rules. In August, the Court of Appeals unanimously dismissed the Trump administration’s request to overturn the lower court’s decision. Two weeks later, the Trump administration went to the Supreme Court and demanded that it block lower court orders.
In that request, FDA lawyers wrote that drugs used for drug abortion “carry serious risks, including bleeding that requires surgical intervention, and direct dispensing reduces those risks.” I have.
In January, the judge allowed the Trump administration to revive face-to-face requirements and overturn lower court decisions. The Supreme Court’s decision was the first major proceeding to abortion since Judge Amy Coney Barrett was confirmed last fall.
However, Monday’s announcement invalidates the court’s January decision, given that the rule changes are from the FDA itself, not the lower court.
On Monday night, ACOG CEO Maureen G. Phipps said in a statement that he would “praise” the FDA’s decision.
“By suspending the enforcement of face-to-face dispensing requirements during the COVID-19 pandemic, the FDA recognizes and responds to available evidence. This is due to the lack of face-to-face dispensing requirements for mifepristone. It clearly and clearly shows that it is necessary and restrictive, “Phips said.
However, Monday’s decision only lifts the face-to-face requirement during the pandemic. It remains unclear how the administration will deal with future restrictions.
Biden administration to lift abortion drug restrictions in a pandemic
Source link Biden administration to lift abortion drug restrictions in a pandemic